NATIONAL CANCER INSTITUTE - CANCER.GOV

Search Results for: R24 Chimeric

Total Results Found: 2

Total Results Found: 2

Biopharmaceutical Development Program (BDP)
Frederick, MD

Collaborative

The Biopharmaceutical Development Program (BDP) provides resources for the development of investigational biological agents. The BDP supports feasibility through development and Phase I/II cGMP manufacturing plus regulatory documentation. BDP is a DCTD-dedicated facility, but Read More...

NIH Clinical Center, Center for Cellular Engineering
Bethesda, MD

Core Facility

Trans NIH Facility

The Center of Cellular Engineering (CCE) is a comprehensive facility that develops and manufactures a wide range of cell and gene therapies for early phase clinical trials. The CCE is currently manufacturing chimeric antigen receptor ( Read More...